Irinoten 40 Irinotecan

Get a Price/Quote

MOQ : 50 Vials

Irinoten 40 Irinotecan Specification

Salt Composition
Irinotecan Hydrochloride

Dosage Form
Injection

Indication
Colorectal Cancer

Feature
Single use vial, IV use

Ingredients
Irinotecan Hydrochloride

Application

Physical Color/Texture
Clear solution (visual assumption)

Storage Instructions
Store below 25C

Strength
40 mg

Therapeutic Class
Antineoplastic

For Hospital Use
Yes

Box Color
Yellow-white

Intended Route
IV administration

Vial Volume
2 ml

Prescription Required
Yes

Strength per ml
20 mg/ml

Manufacturer Details
Not visible

Packaging Type
Single Vial Pack

Irinoten 40 Irinotecan Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Irinoten 40 Irinotecan

Discover the trending and rare Irinoten 40 Irinotecan, a top-drawer antineoplastic injection designed for transcendent clinical performance. Crafted for hospital use, this finest single-use vial offers 40 mg of Irinotecan Hydrochloride in a clear, high-quality solution with a strength of 20 mg/ml. Its limited stock and unique yellow-white packaging make it highly sought-after among oncologists and healthcare professionals. Specifically indicated for colorectal cancer, Irinoten 40 ensures effective chemotherapy through IV administration-prescribed by experts for those seeking the most advanced treatment solutions available on the market.

Specialized Application Across Oncology Settings

Irinoten 40 Irinotecan is highly effective in application areas involving anti-cancer chemotherapy, particularly for advanced or metastatic colorectal cancer. Tailored for intravenous media, its single-use vial format ensures optimal potency for each patient. Frequently used in hospitals and oncology clinics, Irinoten 40 supports plant application workflows by streamlining cancer treatment protocols, enhancing both accuracy and therapeutic impact for medical professionals.

Sample Availability, Market Arrival, and Global Export Reach

Samples of Irinoten 40 Irinotecan are readily available upon request, aiding healthcare providers in making informed decisions before full-scale adoption. Recently arrived in major export markets, this product is positioned competitively in both international and domestic markets. The list price is tailored for bulk orders, especially for Indian and global buyers. The product's limited supply and unparalleled demand highlight its status as an in-demand chemotherapy solution for both domestic and overseas clientele.

FAQ's of Irinoten 40 Irinotecan:

Q: How is Irinoten 40 Irinotecan administered?

A: Irinoten 40 Irinotecan is given via intravenous (IV) infusion under the supervision of a healthcare professional in a hospital setting.

Q: What is the main therapeutic use of Irinoten 40 Irinotecan?

A: This product is primarily indicated for the treatment of colorectal cancer, functioning as an important antineoplastic agent during chemotherapy regimens.

Q: Where is Irinoten 40 Irinotecan typically applied?

A: Irinoten 40 is used in hospitals and oncology clinics where advanced chemotherapy for colorectal cancer patients is conducted and managed.

Q: When should Irinoten 40 Irinotecan be stored?

A: The vial should be stored below 25C in a controlled environment until it is ready for single-use administration.

Q: What distinguishes Irinoten 40 from similar products?

A: Irinoten 40 is trending due to its rare availability, limited stock, and consistent efficacy, making it a preferred choice for oncologists globally.